The links are for required readings found in the Walden databases ONLY. For all other readings, see your course resources.
Enter your myWalden user name and password at the prompt.
Bruera, E., & Neumann, C. M. (1998). The uses of psychotropics in symptom management in advanced cancer. Psycho-Oncology, 7(4), 346–358.
Buclin, T., Mazzocato, C., Berney, A., & Stiefel, F. (2001). Psychopharmacology in supportive care of cancer: A review for the clinician: IV. Other psychotropic agents. Supportive Care in Cancer, 9(4), 213–222.
Cullivan, R., Crown, J., & Walsh, N. (1998). The use of psychotropic medication in patients referred to a psycho-oncology service. Psycho-Oncology, 7(4), 301–306.
Edwards, S. & Koob, G. F. (2010). Neurobiology of dysregulated motivational systems in drug addiction. Future Neurology, 5(3), 393–401.
Gilpin, N., Smith, A., Cole, M., Weiss, F., Koob, G., & Richardson, H. (2009). Operant behavior and alcohol levels in blood and brain of alcohol-dependent rats. Alcoholism, Clinical And Experimental Research, 33(12), 2113-2123.
Kenemans, J. L., & Kähkönen, S. (2011). How human electrophysiology informs psychopharmacology: From bottom-up driven processing to top-down control. Neuropsychopharmacology, 36(1), 26–51.
Koob, G. F., & Volkow, N. D. (2010). Neurocircuitry of addiction. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology, 35(1), 217–238.
Murnane, K. S., & Howell, L. L. (2011). Neuroimaging and drug taking in primates. Psychopharmacology, 216(2), 153–171.
Niv, N., Shatkin, J., Hamilton, A., Unützer, J., Klap, R., & Young, A. (2010). The Use of Herbal Medications and Dietary Supplements by People with Mental Illness. Community Mental Health Journal, 46(6), 563-569
Noble, M., Tregear, S. J., Treadwell, J. R., & Schoelles, K. (2008). Long-term opioid therapy for chronic noncancer pain: A systematic review and meta-analysis of efficacy and safety. Journal of Pain and Symptom Management, 35(2), 214–228.
Sigmon, S. C., Herning, R. I., Better, W., Cadet, J. L., & Griffiths, R. R. (2009). Caffeine withdrawal, acute effects, tolerance, and absence of net beneficial effects of chronic administration: Cerebral blood flow velocity, quantitative EEG, and subjective effects. Psychopharmacology, 204(4), 573–585.
Stiefel, F., Bernery, A., & Mazzocato, C. (1999). Psychopharmacology in supportive care of cancer: A review for the clinician: I. Benzodiazepines. Supportive Care in Cancer, 7(6), 379–385.
Warbrick, T., Mobascher, A., Brinkmeyer, J., Musso, F., Stoecker, T., Shah, N. J., Vossel, S., & Winterer, G. (2011). Direction and magnitude of nicotine effects on the fMRI BOLD response are related to nicotine effects on behavioral performance. Psychopharmacology, 215(2): 333–344.
Optional or supplemental readings may or may not be available in the library. Find further information about optional readings here.
If you have questions about your required course textbooks, please contact Customer Care at email@example.com